Nicergoline Tablets

This product is a semi-synthetic ergot alkaloid derivative. It has alpha-receptor blocking and vasodilation effects. It can enhance the metabolism of brain cell energy and increase the utilization of oxygen and glucose. It promotes the conversion of neurotransmitter dopamine to increase nerve conduction, strengthens the synthesis of brain protein, and improves brain function.

The main ingredient of this product is nicergoline, with the chemical name of 10alpha;-methoxy-1,6-dimethylergoline-8beta;-methanol-5-bromonicotinate. Molecular formula: C24H26O3N3Br Molecular weight: 484.392

This product is a white film-coated tablet for 10 mg and a yellow film-coated tablet for 30 mg. The tablet appears white after removing the film coating.

1. Improve low desire and emotional disorders (slow reaction, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.) caused by cerebral arteriosclerosis and sequelae of cerebral stroke. 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc., and can reduce the severity of the disease.

Oral administration, do not chew. 20~60mg per day, divided into 2~3 doses. Continuous administration for a sufficient period of time, at least six months; whether to continue administration is determined by the doctor.

No serious adverse reactions have been reported. There may be hypotension, dizziness, stomach pain, hot flashes, facial flushing, drowsiness, insomnia, etc. In clinical trials, an increase in uric acid concentration in the blood was observed, but this phenomenon was not related to the dosage and administration time.

This product is not suitable for the following situations: recent myocardial infarction, acute bleeding, severe bradycardia, orthostatic regulation dysfunction, bleeding tendency and allergy to nicergoline

Precautions for children: According to the current indications, this drug is not for children. Precautions for pregnancy and lactation: Toxicity tests failed to show the teratogenic effect of nicergoline. The indications of this drug show that this drug is not for pregnant and lactating women. Precautions for the elderly: Pharmacokinetic and tolerability tests show that there is no difference in dosage and administration method between adults and elderly patients.

Nicergoline tablets may enhance the effects of antihypertensive drugs. Since nicergoline is metabolized by CYTP4502D6, interactions with drugs that are metabolized by the same pathway cannot be ruled out.

Keep away from light and store in sealed container.

10mg

36 months.

Kun Shan Rotam Reddy Pharmaceutical Co., Ltd.

• Founded in:

  1993-12-31

• Address:

  No. 2158 Huangpujiang Middle Road, Kunshan Development Zone, Jiangsu Province

• Tax NO.:

  91320583608278334C

• Registered Funds:

  $25,416,780

• Website:

  Log in to view

• Email:

  Log in to view